Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54348

Title:	Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study
Authors:	Abad-Sazatornil, María Reyes Arenaza, Ainhoa Bayo, Juan García Mata, Jesus Guinea De Castro, José María León, Josefa Letéllez Fernández, Javier Reguero, Virginia Martínez Chamorro, Carmen Salar, Antonio View more
Filiation:	Servicio de Farmacia. Hospital Universitario de Fuenlabrada
Keywords:	Efficiency indicators Healthcare capacity Healthcare quality Intravenous Resource optimization Subcutaneous View more
Mesh:	Injections, Subcutaneous Trastuzumab Rituximab Efficiency Spain View more
Decs:	España Eficiencia Trastuzumab Rituximab Inyecciones Subcutáneas View more
Issue Date:	8-Apr-2021
Citation:	BMC Health Serv Res.2021 Apr;(21)1:320
Abstract:	Subcutaneous (SC) versus intravenous (IV) administration is advantageous in terms of patient convenience and hospital efficiency. This study aimed to compare the effect of optimizing the processes involved in SC versus IV administration of rituximab and trastuzumab on hospital capacity and service quality.
PMID:	33832464
URI:	https://hdl.handle.net/20.500.12530/54348
Rights:	info:eu-repo/semantics/openAccess
Appears in Collections:	Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:

File	Description	Size	Format
BMC Health Services Research.pdf		964.44 kB	Adobe PDF	View/Open

This item is licensed under a Creative Commons License